These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 603760)

  • 21. Chronic myeloproliferative disorders: improved platelet aggregation following venesection.
    Boughton BJ
    Br J Haematol; 1978 Aug; 39(4):589-98. PubMed ID: 698130
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of splenectomy on platelet morphometry and function.
    Wehmeier A; Scharf RE; Schneider W
    Klin Wochenschr; 1990 Sep; 68(17):847-52. PubMed ID: 2214608
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blood platelet calcium content and aggregation behaviour in myeloproliferative disorders and secondary thrombocytosis.
    Mindner K; Ostermann G; Hochhaus A; Höche D; Till U
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(4):461-4. PubMed ID: 2465953
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differing beta-blocking effects of carvedilol and metoprolol.
    Stoschitzky K; Koshucharova G; Zweiker R; Maier R; Watzinger N; Fruhwald FM; Klein W
    Eur J Heart Fail; 2001 Jun; 3(3):343-9. PubMed ID: 11378006
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of an isoprenaline infusion on the splenic blood flow and intrasplenic platelet kinetics.
    Wadenvik H; Kutti J
    Eur J Haematol; 1987 Jul; 39(1):7-13. PubMed ID: 3653374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelet storage in the spleen in idiopathic thrombocytopenic purpura and congestive splenomegaly.
    Burger T; Kelényi G; Kett K; Kutas J; Schmelczer M; Szilágyi K
    Acta Med Acad Sci Hung; 1976; 33(1):13-24. PubMed ID: 1035832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Different effects of beta-1-adrenergic blocking agents with ISA or without ISA on peripheral blood flow.
    Karnik R; Valentin A; Slany J
    Angiology; 1987 Apr; 38(4):296-303. PubMed ID: 2883920
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The peripheral platelet count in response to intravenous infusion of isoprenaline.
    Olsson LB; Kutti J; Lundborg P; Fredén K
    Scand J Haematol; 1976 Sep; 17(3):213-6. PubMed ID: 968451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective beta 1 and beta 2 adrenoceptor blockade on epinephrine-induced arrhythmias in halothane anaesthetized dogs.
    Hayashi Y; Sumikawa K; Kamibayashi T; Yamatodani A; Mammoto T; Kuro M; Yoshiya I
    Can J Anaesth; 1992 Oct; 39(8):873-6. PubMed ID: 1283841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prediction of the splenectomy efficacy in chronic immune thrombocytopenic purpura].
    Todorović-Tirnanić M; Obradović V; Rolović Z; Suvajdzić N; Elezović I; Colović M; Pavlović S; Bosnjaković V
    Glas Srp Akad Nauka Med; 2005; (48):119-35. PubMed ID: 16405235
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo platelet release in myeloproliferative disorders.
    Ireland H; Lane DA; Wolff S; Foadi M
    Thromb Haemost; 1982 Aug; 48(1):41-5. PubMed ID: 6215739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platelet activation in myeloproliferative disorders.
    Cortelazzo S; Viero P; Barbui T
    Thromb Haemost; 1981 Jun; 45(3):211-3. PubMed ID: 6169172
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential effect of chronic treatment with two beta-blocking agents on insulin sensitivity: the carvedilol-metoprolol study.
    Jacob S; Rett K; Wicklmayr M; Agrawal B; Augustin HJ; Dietze GJ
    J Hypertens; 1996 Apr; 14(4):489-94. PubMed ID: 8761899
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pafenolol, a highly selective beta 1-adrenoceptor-antagonist, in asthmatic patients: interaction with terbutaline.
    Löfdahl CG; Marlin GE; Svedmyr N
    Clin Pharmacol Ther; 1983 Jan; 33(1):1-9. PubMed ID: 6129091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemodynamic effects of intravenous metoprolol.
    Bourdillon PD; Canepa-Anson R; Rickards AF
    Am J Cardiol; 1979 Nov; 44(6):1195-200. PubMed ID: 495515
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A pharmacokinetic and platelet function study of the combined administration of metoprolol and sulfinpyrazone to healthy volunteers.
    Cortellaro M; Boschetti C; Antoniazzi V; Polli EE; de Gaetano G; De Blasi A; Gerna M; Pezzi L; Garattini S
    Thromb Res; 1984 Apr; 34(1):65-74. PubMed ID: 6729769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of cold exposure on submaximal exercise performance and adrenergic activation in patients with congestive heart failure and the effects of beta-adrenergic blockade (carvedilol or metoprolol).
    Blanchet M; Ducharme A; Racine N; Rouleau JL; Tardif JC; Juneau M; Marquis J; Larivée L; Nigam A; Fortier A; White M
    Am J Cardiol; 2003 Sep; 92(5):548-53. PubMed ID: 12943875
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of beta-adrenoceptor selectivity of a new beta-adrenoceptor antagonist, bisoprolol, in man.
    Tattersfield AE; Cragg DJ; Bacon RJ
    Br J Clin Pharmacol; 1984 Sep; 18(3):343-7. PubMed ID: 6148959
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antihypertensive effect of a non-selective (propranolol) and a cardioselective (metoprolol) beta-adrenoceptor blocking agent at rest and during exercise.
    Clausen N; Damsgaard T; Mellemgaard K
    Br J Clin Pharmacol; 1979 Apr; 7(4):379-83. PubMed ID: 375959
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beta 1-blockade and acute coronary ischemia. Possible role of platelets.
    Winther K; Willich SN
    Circulation; 1991 Dec; 84(6 Suppl):VI68-71. PubMed ID: 1959217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.